Treatment-Resistant Depression (TRD)
For adults who have tried two or more antidepressants without adequate relief. SPRAVATO® can interrupt the cycle of partial response and plateaued mood gains.
SPRAVATO® Care
SPRAVATO® (Esketamine) Treatment at Find Your Light Psychiatry
A breakthrough option for adults with treatment-resistant depression—delivered in a calm, private space with continuous monitoring, compassionate support, and full insurance coordination.
Covered by many major insurance plans • Supervised by PMHNP-BC
Clinical Overview
What Is SPRAVATO®?
SPRAVATO® (esketamine) is an FDA-approved nasal spray that pairs with an oral antidepressant to target stubborn depressive symptoms through the NMDA receptor pathway—something traditional SSRIs and SNRIs don’t directly address.
Major Depressive Disorder with Acute Suicidal Ideation or Behavior
Provides a rapidly acting option for adults experiencing significant depressive symptoms alongside active or recent suicidal thoughts.
Because SPRAVATO® acts on glutamate transmission instead of solely on serotonin or norepinephrine, many patients report meaningful improvements within 4–6 weeks along with greater stability, motivation, and clarity.
In-Clinic Flow
How SPRAVATO® Works
SPRAVATO® is administered in clinic under continuous supervision. Each appointment lasts about two hours so we can ensure the medication is working effectively and safely.
01
Self-administer in clinic
You comfortably self-administer the nasal spray while seated in a private treatment suite.
02
Rest & reset for ~2 hours
We provide a calm environment with dimmed lights, blankets, and continuous observation while the medication takes effect.
03
Safety monitoring & discharge
Vitals are monitored at regular intervals. Once you feel steady—and a support person is present—you’re cleared to head home.
Patient Wins
Benefits Patients Frequently Experience
Every nervous system is unique, yet many patients describe the following improvements as they move through the treatment series.
Treatment Timeline
Treatment Schedule
Plans are customized for each person—but here’s the cadence most adults follow as we taper to meet your stability goals.
Weeks 1–42 treatments per week
Builds momentum quickly while your brain creates new glutamate pathways.
Weeks 5–81 treatment per week
Stabilizes gains, reduces symptom spikes, and reinforces new neural connections.
Week 9+Every 1–2 weeks
Maintenance visits are tailored to your progress, therapy schedule, and goals.
Insurance & Billing
Insurance Coverage
SPRAVATO® is covered by many major insurance plans. Our dedicated team handles the approvals so you can focus on healing.
Benefit verification and coordination with payers
Prior authorization submissions and tracking
On-going documentation for continued coverage
Transparent billing + patient support every step
Where We Treat
Our Locations
Calm, private suites in Bellevue and Seattle with on-site monitoring, complimentary refreshments, and easy parking.
Bellevue Office
14535 Bel-Red Road, Suite 200Bellevue, WA 98007Seattle – Queen Anne Office
200 First Ave West, #400Seattle, WA 98119Phone
425-780-7460Eligibility
Who Qualifies?
You may be a good candidate if you resonate with the following. Every patient receives a comprehensive psychiatric evaluation before beginning treatment.
Tried two or more antidepressants without enough relief
Still experience significant depressive symptoms
Have active or recent suicidal thoughts
Prefer a fast-acting, insurance-supported option
Value structured follow-up with medication + therapy
FAQs
Frequently Asked Questions
Have more questions? Send us a note through the contact form and a clinician will respond within one business day.
How long is each SPRAVATO® visit?
Plan for about two hours in clinic. This covers self-administration, a restful recovery period, snack/refreshment time, and our final safety check before you leave with a support person.
Is SPRAVATO® covered by insurance?
Many commercial plans and select public plans cover SPRAVATO®. We verify benefits, submit authorizations, and manage documentation so there are no surprises.
What’s the difference between SPRAVATO® and IV ketamine?
SPRAVATO® is the only FDA-approved esketamine nasal spray. It’s administered in clinic with strict safety protocols and insurance support. IV ketamine is an off-label infusion that is typically self-pay.
Can I drive after treatment?
No. You’ll need a trusted support person to drive you home and stay with you for the remainder of the day. Most patients feel back to baseline the following morning.
How quickly will I feel results?
Some patients notice mood shifts within the first few sessions. Most experience significant improvement between weeks 4–6 when the full treatment schedule is followed.
What are the common side effects?
Temporary dissociation, dizziness, or mild nausea can occur shortly after dosing. We monitor vitals, provide comfort measures, and symptoms typically resolve before discharge.
Ready to begin?
Request your SPRAVATO® consultation today.